Claim(permalink)
A treatment for a serious disease that costs $900 in India is sold for $84,000 in the United States because of corporate greed.
Factors
veracity
Political Leaning
Sentiment
Date published
2016-05-02
Entities
MarsPatent infringementMiracle DrugHealth systemCriticism of capitalismHepatitis CBlood transfusionKingdom of EnglandCocktailDeveloped countryRationingTen PercentFederal government of the United StatesDeveloping countryClinical trialPharmaceutical industryThe Wall Street JournalMerck GroupMedicationSoviet UnionIncome taxUnited States dollarMemePresidency of Barack ObamaNorwayCourtCanadaEuropean UnionCaliforniaIndiaPatent attorneyBloodborneRichard J. EvansMolecular entityGovernment of OntarioLaw of the United StatesClean handsHepatocellular carcinomaHepatitisIndividualismCandor ChasmaPrice controlsGeneric drugCirrhosisThe Challenge (TV series)Gilead SciencesBiopharmaceutical
